Johnson & Johnson
Medicines and medical technology for hospitals worldwide.
52-week range
As of 5 Oct 2026, 17:51What does Johnson & Johnson do?
Johnson & Johnson, based in New Brunswick, New Jersey, is now a pure healthcare company. About two thirds of revenue comes from medicines, for example for cancer, psoriasis or depression. The rest is medical technology: surgical tools, heart catheters, joint replacements and contact lenses. Consumer brands like Listerine and Neutrogena were spun off in 2023.
From Acuvue contact lenses at the optician and, without noticing, from surgical supplies and medicines in hospital.
How Johnson & Johnson makes money
- Medicines64 %
- Medical technology36 %
Strengths
- Broadly positioned, with many medicines that each sell billions.
- People get sick in recessions too, which keeps the business stable.
- One of the few companies with the top AAA credit rating, and a dividend that rose in 2026 for the 64th year in a row.
Risks
- When patents expire, cheap copies arrive, as is happening now with the drug Stelara.
- Tens of thousands of lawsuits over talc baby powder have weighed on the company for years.
- Pressure on US drug prices, plus dollar risk for euro investors.
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Employees
- about 138,000
What if you had invested in Johnson & Johnson earlier?
Similar stocks
+63.1%Bayer
Medicines and seeds from Leverkusen, for over 160 years.
+19.9%Merck
The world’s oldest pharma and chemicals company, since 1668.
-22.9%Siemens Healthineers
MRI, CT and cancer therapy: medical technology from Erlangen.
-12.3%Fresenius
Hospitals and IV drips from Bad Homburg.
This page explains the company and is not a recommendation to buy or sell.